Search Results - "AUBERT, V"

Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? by Kletenkov, K, Hoffmann, D, Böni, J, Yerly, S, Aubert, V, Schöni-Affolter, F, Struck, D, Verheyen, J, Klimkait, T

“…HIV Gag mutations have been reported to confer PI drug resistance. However, clinical implications are still controversial and most current genotyping…”
Get full text

Identification of a novel HLA‐B18 allele, B18:119, using sequence‐based typing in a caucasoid individual by André, C., Pantaleo, G., Aubert, V.

“…HLA‐B*18:119 differs from HLA‐B*18:01:01 at nucleotide 28 C>T in exon 4 changing histidine to tyrosine…”
Get full text

Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis by Wassenberg, J., Nutten, S., Audran, R., Barbier, N., Aubert, V., Moulin, J., Mercenier, A., Spertini, F.

“…Cite this as: J. Wassenberg, S. Nutten, R. Audran, N. Barbier, V. Aubert, J. Moulin, A. Mercenier and F. Spertini, Clinical & Experimental Allergy, 2011 (41)…”
Get full text

Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study by Béguelin, Charles, Suter, Annatina, Bernasconi, Enos, Fehr, Jan, Kovari, Helen, Bucher, Heiner C., Stoeckle, Marcel, Cavassini, Mathias, Rougemont, Mathieu, Schmid, Patrick, Wandeler, Gilles, Rauch, Andri, Aubert, V, Battegay, M, Böni, J, Braun, DL, Calmy, A, Ciuffi, A, Dollenmaier, G, Egger, M, Elzi, L, Fellay, J, Furrer, H, Fux, CA, Günthard, HF, Haerry, D, Hasse, B, Hirsch, HH, Hoffmann, M, Hösli, I, Kahlert, C, Kaiser, L, Keiser, O, Klimkait, T, Kouyos, RD, Ledergerber, B, Martinetti, G, Tejada, B, Marzolini, C, Metzner, KJ, Müller, N, Nicca, D, Pantaleo, G, Paioni, P, Rudin, C, Scherrer, AU, Speck, R, Stöckle, M, Tarr, P, Trkola, A, Vernazza, P, Weber, R, Yerly, S

“…Background & Aims Hepatitis C virus (HCV) therapies with interferon‐free second‐generation direct‐acting antivirals (DAAs) are highly effective and well…”
Get full text

HEV as a cause of acute hepatitis acquired in Switzerland by Christinet, M.F, Doerig, C, Moulin, H, Bihl, F, Brunner, F, Müllhaupt, B, Semela, D, Stickel, F, Beretta-Piccoli, B.T, Aubert, V, Telenti, A, Greub, G, Sahli, R, Moradpour, D

Get full text

Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection by Metzner, Karin J., Scherrer, Alexandra U., Preiswerk, Benjamin, Joos, Beda, von Wyl, Viktor, Leemann, Christine, Rieder, Philip, Braun, Dominique, Grube, Christina, Kuster, Herbert, Böni, Jürg, Yerly, Sabine, Klimkait, Thomas, Aubert, Vincent, Furrer, Hansjakob, Battegay, Manuel, Vernazza, Pietro L., Cavassini, Matthias, Calmy, Alexandra, Bernasconi, Enos, Weber, Rainer, Günthard, Huldrych F.

“…Background. Drug-resistant human immunodeficiency virus type 1 (HIV-1) minority variants (MVs) are present in some antiretroviral therapy (ART)-naive patients…”
Get full text

49 Lumacaftor/ivacaftor (LUM/IVA) treatment in patients (pts) with cystic fibrosis (CF) aged ≥12 years homozygous for F508del-CFTR : description of a French Temporary Authorization for Use (ATU) cohort by Chiron, R, Hubert, D, Reix, P, Collas-Aubert, V, Tian, S, Kiefer, P, Kinnman, N

Get full text

Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships by Marzel, A, Shilaih, M, Turk, T, Campbell, NK, Yang, W‐L, Böni, J, Yerly, S, Klimkait, T, Aubert, V, Furrer, H, Calmy, A, Battegay, M, Cavassini, M, Bernasconi, E, Schmid, P, Metzner, KJ, Günthard, HF, Kouyos, RD, Bucher, H. C., Burton‐Jeangros, C., Dollenmaier, G., Egger, M., Elzi, L., Fehr, J., Fellay, J., Fux, C. A., Gorgievski, M., Haerry, D., Hasse, B., Hirsch, H. H., Hoffmann, M., Hösli, I., Kahlert, C., Kaiser, L., Keiser, O., Kovari, H., Ledergerber, B., Martinetti, G., Tejada, B. Martinez, Müller, N., Nadal, D., Nicca, D., Pantaleo, G., Rauch, A., Regenass, S., Rickenbach, M., Rudin, C., Schöni‐Affolter, F., Schmid, P., Schüpbach, J., Speck, R., Tarr, P., Trkola, A., Vernazza, P., Weber, R., Yerly, S.

“…Objectives Here we examined the hypothesis that some stable HIV‐infected partnerships can be found in cohort studies, as the patients frequently attend the…”
Get full text

Hirsutisme révélateur d’une tumeur ovarienne à cellules stéroïdes non spécifique : à propos d’un cas by Demarquet, L, Aubert, V

“…Introduction Les tumeurs ovariennes à cellules stéroïdes non spécifiques représentent 60 % des tumeurs ovariennes à cellules stéroïdes et moins de 0,1 % des…”
Get full text

Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells by Zurn, A D, Henry, H, Schluep, M, Aubert, V, Winkel, L, Eilers, B, Bachmann, C, Aebischer, P

“…A phase I/II clinical trial has been performed in 12 amyotrophic lateral sclerosis (ALS) patients to evaluate the safety and tolerability of intrathecal…”
Get full text

Recurrent ibuprofen-induced aseptic meningitis: evidence against an antigen-specific immune response by Periard, D, Mayor, C, Aubert, V, Spertini, F

Get full text

Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kindney transplantation by Aubert, V, Pascual, M, Andresen, I

Get full text

P62 - Vécu du passage à l’insuline des patients diabétiques de type 2 âgés de plus de 65 ans by Béraud, M, Malvaux, S, Créa, T, Laguerre, N, Aubert, V, Potier, R, Cuny, P

“…Introduction Plus de la moitié des diabétiques de type 2 sont âgés de plus de 65 ans. Nous avons étudié le ressenti du passage à un traitement injectable par…”
Get full text

P77 - Perception des médecins généralistes du ressenti de leurs patients diabétiques de plus de 65 ans vis-à-vis de l’insuline by Béraud, M, Malvaux, S, Créa, T, Laguerre, N, Aubert, V, Potier, R, Cuny, P

“…Introduction Plus de 90 % des patients DT2 sont suivis par leur médecin généraliste. Le passage à l’insuline est un moment délicat dans la vie d’un patient…”
Get full text

147P Blind validation of an AI-based tool for predicting distant relapse from breast cancer HES stained slides by Garberis, I.J., Gaury, V., Aubert, V., Drubay, D., Saillard, C., Elgui, K., F. Bernigole, Jacquet, A., André, F., Lacroix-Triki, M.

Get full text

P235 Serum VEGF-D level as a diagnostic biomarker of lymphangioleiomyomatosis in clinical practice by Daccord, C., Aubert, V., Félix, N., Lazor, R.

Get full text

Adverse events of raltegravir and dolutegravir by Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel

“…To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. Prospective cohort study. All…”
Get full text

1124O Prediction of distant relapse in patients with invasive breast cancer from deep learning models applied to digital pathology slides by Garberis, I.J., Saillard, C., Drubay, D., Schmauch, B., Aubert, V., Jaeger, A., Sapateiro, M., de Lavergne, A., Kamoun, A., Courtiol, P., André, F., Lacroix-Triki, M.

Get full text

A highly virulent variant of HIV-1 circulating in the Netherlands by Wymant, Chris, Bezemer, Daniela, Blanquart, François, Ferretti, Luca, Gall, Astrid, Hall, Matthew, Golubchik, Tanya, Bakker, Margreet, Ong, Swee Hoe, Zhao, Lele, Bonsall, David, de Cesare, Mariateresa, MacIntyre-Cockett, George, Abeler-Dörner, Lucie, Albert, Jan, Bannert, Norbert, Fellay, Jacques, Grabowski, M Kate, Gunsenheimer-Bartmeyer, Barbara, Günthard, Huldrych F, Kivelä, Pia, Kouyos, Roger D, Laeyendecker, Oliver, Meyer, Laurence, Porter, Kholoud, Ristola, Matti, van Sighem, Ard, Berkhout, Ben, Kellam, Paul, Cornelissen, Marion, Reiss, Peter, Fraser, Christophe, Aubert, V, Battegay, M, Bernasconi, E, Böni, J, Braun, D L, Bucher, H C, Burton-Jeangros, C, Calmy, A, Cavassini, M, Dollenmaier, G, Egger, M, Elzi, L, Fehr, J, Fellay, J, Furrer, H, Fux, C A, Gorgievski, M, Günthard, H, Haerry, D, Hasse, B, Hirsch, H H, Hoffmann, M, Hösli, I, Kahlert, C, Kaiser, L, Keiser, O, Klimkait, T, Kouyos, R, Kovari, H, Ledergerber, B, Martinetti, G, de Tejada, B Martinez, Marzolini, C, Metzner, K, Müller, N, Nadal, D, Nicca, D, Pantaleo, G, Rauch, A, Regenass, S, Rudin, C, Schöni-Affolter, F, Schmid, P, Speck, R, Stöckle, M, Tarr, P, Trkola, A, Vernazza, P, Weber, R, Yerly, S, van der Valk, M, Geerlings, S E, Goorhuis, A, Hovius, J W, Lempkes, B, Nellen, F J B, van der Poll, T, Prins, J M, Reiss, P, van Vugt, M, Wiersinga, W J, Wit, F W M N, van Duinen, M, van Eden, J, Hazenberg, A, van Hes, A M H, Pijnappel, F J J, Smalhout, S Y

“…We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred nine individuals with this variant had a 0.54 to 0.74 log increase…”
Get full text

EP-1598: Modelisation of radiation response at various fractionation from histopathological prostate tumors by Aubert, V., Acosta, O., Rioux-Leclercq, N., Mathieu, R., Commandeur, F., De Crevoisier, R.

Get full text